
Keywords: Mycobacterium tuberculosis; RmlB; Microtiter plate assay; Kinetic properties; Inhibitor; High-throughput screeningTB, tuberculosis; MDR, multidrug-resistant; Mtb, Mycobacterium tuberculosis; PG, peptidoglycan; AG, arabinogalactan; RmlA, d-glucose-1-phosph